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whole blood with commercial therapeutic
feline hydrolyzed diets in individual healthy
immunotolerant cats
Aarti Kathrani1,3* , Jennifer A. Larsen2, Gino Cortopassi2, Sandipan Datta2 and Andrea J. Fascetti2Abstract
Background: Hydrolyzed diets are used in companion animals for the diagnosis and treatment of adverse food
reaction. Similarly, hydrolyzed formulas are used in human infants with severe inflammatory bowel disease or milk
allergy, and these must meet the standard of hypoallergenicity through rigorous testing. Unfortunately, no standards are
currently applied to hydrolyzed veterinary therapeutic diets, and data for the immunogenicity of feline diets is also not
available. Therefore, the main aim of this pilot study was to determine if ex-vivo whole blood stimulation assays could be
used to characterize the cytokine response to hydrolyzed commercial diets in a small number of individual healthy
immunotolerant cats. This approach has also been used to investigate cytokine production in response to cow milk
protein in humans and currently similar studies do not exist in companion animals. Nine healthy cats previously eating
the same basal diet were divided into groups and fed one of three hydrolyzed diets exclusively for 6 weeks. Heparinized
whole blood was collected from each cat before and after the feeding trial. Ex-vivo whole blood stimulation assays were
performed using crude extracts of the basal diet as a positive control, as this diet contained the same proteins present in
the hydrolyzed diet but were intact, saline as a negative control, and each cat’s respective hydrolyzed diet. Supernatants
were collected and analyzed for tumor necrosis factor-alpha, interleukin-10 (IL-10), and interleukin-4 using enzyme-linked
immunosorbant assay.
Results: Seven cats produced detectable amounts of the anti-inflammatory cytokine IL-10 upon stimulation with the
basal diet. Two cats produced detectable amounts of IL-10 upon stimulation with a hydrolyzed soy-based diet and one
cat produced a detectable amount of IL-10 upon stimulation with a hydrolyzed chicken-based diet (>125 pg/mL).
Conclusions: Results from this pilot study suggest that in some healthy immunotolerant cats, some hydrolyzed diets
may elicit a similar cytokine response compared to their basal diet, which contained the same proteins intact.
Therefore, animals may be able to recognize and react to some hydrolyzed forms of tolerated proteins, and may also
suggest IL-10 as a target for investigation as a potential marker for dietary tolerance in cats, however further studies
would be necessary to corroborate this. Further studies are also needed to determine if this would also be the same in
immunologically naïve, sensitized and clinically hypersensitized cats.
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Hydrolyzed diets contain peptides created from chem-
ically or enzymatically treated proteins; these peptides
are small enough to theoretically avoid a type 1 hyper-
sensitivity immune response, by preventing cross-linking
of two immunoglobulin E antibody receptors on a mast
cell. A peptide of 10 kDa or less is considered adequate
to avoid this response; however there is evidence to sug-
gest that the size needed may actually be smaller than
three to five kDa [1]. Hydrolyzed diets are used in com-
panion animals to diagnose and treat cutaneous and
gastrointestinal adverse food reactions (AFR) [2]. Like-
wise, hydrolyzed baby formulas are used commonly in
infants with severe inflammatory bowel disease or cow
milk allergy [3]. These formulas must meet the standard
of hypoallergenicity through testing using in vitro and
in vivo animal models as well as clinical assessment [4, 5].
As similar standards are not currently applied to hydrolyzed
pet foods, the proteins in these diets may still retain their
antigenic potential. This was demonstrated in one study,
which indicated that a significant proportion (21%) of dogs
sensitized to the intact protein still reacted adversely to the
hydrolyzed diet [6]. Therefore, the most significant clinical
problem with veterinary hydrolyzed diets may be the
retention of antigenicity leading to continued clinical signs.
Consequently, studies are needed to verify the immuno-
logical potential of these diets.
The current pilot study aimed to describe the immuno-
logical effects of 3 available feline hydrolyzed dry diets in in-
dividual healthy immunotolerant cats before and 6-weeks
after consuming a hydrolyzed diet compared to a basal diet
containing these proteins intact, by measuring cytokine pro-
duction using an ex-vivo whole blood stimulation assay.
This assay has been used to investigate cytokine release in
response to various antigens such as cow milk protein in
humans [7]. Although this ex-vivo protocol has been de-
scribed in dogs using bacterial ligands as a stimulant [8–10];
to the authors’ knowledge this is the first pilot study to use
commercial pet foods as a stimulant in companion animal
studies. We assessed 3 cytokines known to be commonly
modified in adverse immunological responses to food. An
increase in the Th2 cytokine, IL4 and a decrease in the Th2
cytokine, IL10 have been shown to play an important role in
the pathogenesis of food-induced gastrointestinal disorders
in humans and mice [11–13]. Similarly, an increase in the
Th1 cytokine TNF-alpha plays a role in cow-milk allergy in
children and experimental food allergy in mice [14, 15]. The
results of this study will help to describe the immunological
response to hydrolyzed therapeutic diets in individual
healthy immunotolerant adult cats; the results can be subse-
quently compared to immunologically naïve, sensitized and
clinically hypersensitized cats in order to help characterize
the pathogenesis of feline AFR and the role of hydrolyzed
diets in the treatment of this disease.Methods
Cats
Nine healthy intact female, specific pathogen free cats,
residing in an existing colony at the University of California,
Davis were used in this study. No abnormalities were noted
on the basis of pre-study physical examinations. Mean age
was 1.3 years (range 1 to 1.5 years), mean body weight was
3.6 kg (range 3.0 to 4.4 kg), and mean body condition score
was 5/9 [16] (range 4/9 to 6/9). A standardized complete
physical examination was completed on all cats prior to
study initiation. All study cats were born to queens con-
suming the same commercial feline dry diet throughout
gestation and lactation suitable for all life stages based on
feeding trials.1 Following weaning, study cats were then fed
the same dry diet suitable for maintenance2 (basal diet)
until study initiation. This basal diet contained the same
proteins present in the three hydrolyzed diets used in this
study but intact.
Cats were group-housed by dietary treatment and
received daily attention through activities such as petting
and brushing, as well as access to numerous toys and
scratching posts for behavioral enrichment. The facility
maintains room temperatures between 18 and 24 °C,
and has a 14 h light/10 h dark cycle. This experimental
protocol was reviewed and approved by the Institutional
Animal Care and Use Committee (IACUC) of the
University of California, Davis (USA) (Animal Welfare
Assurance Number A3433–01).Study protocol
The cats were allocated to three groups (n = 3) using a
random number generator and were housed by dietary
treatment throughout the study. Cats were adapted to
their respective dietary treatment group while continu-
ing to be fed the basal diet for 7 days prior to the start
of the study (day −7 to 0). All cats had free access to
food and water throughout the study.
At day 0, the basal diet was discontinued and three
cats received a hydrolyzed chicken based diet3 (hydroC
group), three cats received a hydrolyzed soy and chicken
based diet4 (hydroSC group), and the remaining three
cats received a hydrolyzed soy based diet5 (hydroS
group). The hydrolyzed test diets were fed exclusively
for 6 weeks. This duration was based on resolution of
clinical signs in dogs in this time period when treated
for food responsive enteropathy with a hydrolyzed diet
[17]. Body weights and body condition scores were
assessed by the same evaluator (AK) weekly and stool
quality was monitored daily. On days 0 and 43 (at the
start of the study and after the 6-week study period), six
milliliters of blood were collected from each cat via
jugular venipuncture into heparinized tubes following a
12 hour fast.
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stimulation assays
Ten grams of each dry food (the basal diet and each of the
3 hydrolyzed diets)2,3,4,5 collected from a new unopened
bag was ground with sterile water using a clean pestle and
mortar. The mixture was then transferred to a 50 ml sterile
tube6 and incubated overnight at 4-degrees on a rotator.
The tube was centrifuged at 8000 rpm for 1 minute at
room temperature and the supernatant was filtered using a
0.22-μm polyethersulfone sterile filter7 in a sterile tissue
culture hood.8 The protein content in each of the filtrates
was determined using the Bradford assay.9 Working solu-
tions of 500 μg/mL and 50 μg/mL were prepared for each
of the dietary filtrates using phosphate buffered saline.10
These concentrations were chosen based on results of
studies using lymphocyte proliferative assays to various
milk allergens [18, 19].
Blood analysis
Fresh heparinized whole blood, collected within 1 h before
analysis, was mixed with 18 ml of RPMI11 containing peni-
cillin/streptomycinl and 1 ml plated in a 24 well plate.12 A
negative control consisting of 111 uL of phosphate buffered
saline10 and a positive control of 111 uL of 50 μg/mL and
500 μg/mL of basal diet and 111 uL of 50 μg/mL and 500
μg/mL of the respective hydrolyzed diet consumed by that
cat during the 6 week study period were added to each well.
All samples were analyzed in triplicates for a total of 18
wells. All plates were incubated at 37 degrees centigrade at
5% carbon dioxide for 24 h.13 The plates were spun at 2000
x g for 4 min and the supernatant harvested and stored at
−80 °C until analyzed.
The Feline TNF-alpha DuoSet ELISA,14 Feline IL-10
DuoSet ELISA,15 and Feline IL-4 DuoSet ELISA16 were
used to measure TNF-alpha, IL-4, and IL-10 production
in the supernatants according to the manufacturers’
instructions. The triplicate cell culture wells were assayed
individually. The optical density was measured at 450 nm
with a 540 nm wavelength correction using a Bio-Tek
Synergy H1 Multi-Mode,17 Absorbance Reader within
30 min and the data were analyzed using Gen5 Microplate
Reader and Imager Software.18 All assays were performed
in duplicate. The lower limit of detection of the assays was
15.6 pg/mL for TNF-alpha, 125 pg/mL for IL-10 and
62.5 pg/mL for IL-4.
Data analysis
The mean of each of the duplicate cytokine concentra-
tions was calculated. The mean of these values from the
triplicate wells in the ex-vivo whole blood stimulation
assay was then calculated for each of the diets and stan-
dardized to phosphate buffered saline by subtraction.
Differences in age, body weight, and body condition score
between the three groups at inclusion was analyzed usingthe Mann-Whitney U test. A Wilcoxon signed-rank test was
used to compare IL-10 concentrations following stimulation
with the basal diet before and after the 6-week diet trial.
Unfortunately, due to the small number of cats consuming
each of the three hydrolyzed commercial diets, statistical
analysis on cytokine production could not be performed
among groups. Analyses were performed using IBM SPSS
Statistics Version 23. Significance was defined as P ≤ 0.05.
Results
Cats
There were no significant differences in age, body
weight, or body condition score between the three
groups (P > 0.05). All cats remained weight stable and
maintained normal stool quality throughout the 6 week
study period. All cats completed the study.
Ex-vivo whole blood stimulation assays
Numbers of cats that produced detectable amounts of
IL-10, IL-4 and TNF-alpha following stimulation with 50
μg/mL or 500 μg/mL of the basal diet and the respective
hydrolyzed diet before and after 6 weeks of consumption
of hydrolyzed diets are presented in Table 1.
Stimulation with basal diet
On day 0 prior to starting the hydrolyzed diet, 5/9 cats pro-
duced detectable amounts of IL-10 on stimulation with 500
μg/mL of the basal diet (Fig. 1: mean 340.8 pg/mL, range
187.5–457.2 pg/mL). This number increased to 7/9 cats
after consuming their assigned hydrolyzed diet for 6 weeks
(Fig. 1: mean 355.6 pg/mL, range 212.7–503.7 pg/mL).
Although two of the seven cats had lower IL-10 concentra-
tions after 6 weeks compared to baseline (Fig. 1), there was
no significant difference in IL-10 concentrations before and
after 6 weeks (P > 0.05). No cat had detectable IL-10
concentration at baseline that was then undetectable at
6 weeks (Fig. 1). The two remaining cats that did not
produce detectable levels of IL-10 following consumption
of their respective hydrolyzed diet (hydroSC) produced
TNF-alpha when stimulated with 50 μg/mL of the basal
diet (65.8 pg/mL and 34.4 pg/mL respectively), but not on
stimulation with 500 μg/mL of the basal diet.
Stimulation with hydrolyzed diets
One of the three cats in the hydroC group produced a
detectable amount of IL-10 when stimulated with 500 μg/
mL of the hydrolyzed chicken based diet both prior to and
after 6 weeks of consumption (Fig. 2: 230.5 pg/mL and
185.5 pg/mL respectively).
None of the three cats in the hydroSC group produced
detectable amounts of IL-10 following stimulation with
the hydrolyzed soy and chicken based diet prior to or
after 6 weeks of consumption (Fig. 2; <125 pg/mL).
Table 1 Number of cats producing detectable concentrations
of cytokines in ex-vivo whole blood stimulation assays
Cytokine Timepoint Basal diet Respective hydrolyzed diet
50 μg/mL 500 μg/mL 50 μg/mL 500 μg/mL
IL-10 Day 0 0/9 5/9 0/9 2/9
Day 43 0/9 7/9 0/9 3/9
IL-4 Day 0 0/9 0/9 0/9 0/9
Day 43 0/9 0/9 0/9 0/9
TNF-alpha Day 0 0/9 0/9 0/9 0/9
Day 43 2/9 0/9 0/9 0/9
Number of cat blood samples producing detectable concentrations of
interleukin-10 (IL-10), interleukin-4 (IL-4), and tumor necrosis factor-alpha
(TNF-alpha) following ex-vivo whole blood stimulation assay with 50 μg/
mL or 500 μg/mL of pre-study basal diet and the respective hydrolyzed
diet, before and after a 6-week feeding trial of one of 3 hydrolyzed diets
(n = 3 cats per group). No samples produced detectable cytokines
following stimulation with the negative saline control
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tectable amount of IL-10 when stimulated with 500 μg/mL
of the hydrolyzed soy based diet, prior to starting the diet
trial (Fig. 2: 192.2 pg/mL). This same cat and a second cat
produced detectable amounts of IL-10 when stimulated with
500 μg/mL of the hydrolyzed soy based diet after 6 weeks of
consumption (Fig. 2: 380.5 pg/mL and 162.9 pg/mL).
Prior to starting and after 6 weeks of consumption of
their assigned hydrolyzed dietary treatment, no cats inFig. 1 Comparison of interleukin-10 in supernatants from ex-vivo whole bl
concentration in supernatant following ex-vivo whole blood stimulation as
dry food, before and after 6 weeks of consuming the respective hydrolyzedany group produced detectable amounts of TNF-alpha
or IL-4 following stimulation with their respective
hydrolyzed diet (<15.6 pg/mL and <62.5 pg/mL, respectively).Discussion
In this pilot study, an ex-vivo whole blood stimulation
assay was used to describe cytokine production following
stimulation with three commercially available feline
hydrolyzed dry diets before and after feeding exclusively
for 6 weeks compared to a basal diet containing these
proteins intact in a small number of individual healthy
immunotolerant cats with known diet histories. Whole
blood was used in the stimulation assays rather than
peripheral blood mononuclear cells (PBMCs) in order to
mimic the natural environment of the cells, to prevent
phenotypic changes that may occur with isolation of
cells, and to reduce the volume of blood needed. This
technique has been shown to be comparable with the
use of PBMCs [20]. Although whole blood stimulation
assays have been performed using different stimulants
[8, 9] in companion animals, to the authors’ knowledge,
commercial pet foods have not been previously utilized.
Therefore, this pilot study described for the first time,
the cytokine response of feline whole blood when stimu-
lated with different commercial diets.ood stimulation assays using the basal diet. Bar graph of interleukin-10
say for all cats using 500 μg/mL of Purina Cat Chow Complete Formula
diet (group 1 – hydroC, group 2 – hydroSC, and group 3 – hydroS)
Fig. 2 Comparison of interleukin-10 in supernatants from ex-vivo whole blood stimulation assays using hydrolyzed dry diets. Bar graph of interleukin-10
concentration in supernatant following ex-vivo whole blood stimulation assay for all cats using 500 μg/mL of hydrolyzed diet, before and after 6 weeks of
consuming the respective hydrolyzed diet (group 1 – hydroC, group 2 – hydroSC and group 3 – hydroS)
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duced detectable amounts of IL-10 when their whole
blood was directly stimulated with the basal diet. This
may suggest that at least 1 of the mechanisms for im-
munological tolerance to diet in cats may occur via the
production of IL-10. However, further studies utilizing a
negative control that contains protein that the cats have
never been sensitized to, such as sterile human albumin
would be needed to confirm that the IL-10 responses
seen in our study is specific to the dietary antigens
present in the tested diets and therefore may be repre-
sentative of immunological tolerance. Interleukin-10 is
an anti-inflammatory cytokine produced by both the
innate and adaptive immune system and IL-10 is able to
inhibit both Th-1 and Th-2 cytokines, as well as the
expression of autoimmune and pro-inflammatory condi-
tions [21]. One study in humans reported that natural
tolerance to foods was associated with increased
amounts of IL-10 producing peripheral blood mono-
nuclear cells [22]. A second study proposed a role for
serum IL-10 as a useful marker in the diagnosis of food
tolerance in humans [23]. However, further studies will
be needed to determine if IL-10 can be used as a marker
for dietary immunotolerance in companion animals.
Interestingly, this study documented at least a 4-fold
difference in individual IL-10 concentrations when ex-
vivo whole blood was stimulated with the basal diet.
This may be due to differences in peripheral lymphocyte
concentrations between the cats. Unfortunately, theperipheral lymphocyte count was not determined and
therefore the numbers per well for each cat could not be
standardized. Therefore, future studies should focus on
standardizing the number of lymphocytes per well for
each cat as this may then allow for direct comparisons
between individual cats to be made. In addition, healthy
cats have serum antibodies to food proteins [24], there-
fore any antigen specific immunoglobulins in whole
blood from the cats used in our study may have bound
to dietary antigens, resulting in a lower or higher cyto-
kine response depending on the characteristics of the
antibody. This may have also resulted in the variation of
IL-10 concentrations seen in our study. Therefore, future
studies should also focus on the correlation of cytokine
production with dietary antigen specific immunoglobu-
lins to determine the effects of these antibodies on
subsequent cytokine production.
Although this study documented that there was no signifi-
cant difference in IL-10 concentrations following stimulation
with the basal diet before and after 6 weeks of the hydrolyzed
diet (Fig. 1), two of the seven cats had a lower IL-10 concen-
tration after the 6 weeks compared to before. These temporal
differences in IL-10 concentrations in individual cats may
have been due to differences in lymphocyte numbers per well
and dietary antigen specific immunoglobulins at the two time
points. Therefore, future studies should account for the
possibility of variation in lymphocyte counts and dietary anti-
gen specific immunoglobulins when interpreting temporal
differences in cytokine concentrations in individual cats.
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duced detectable IL-10 when stimulated with the hydro-
lyzed diets; one cat to the hydrolyzed chicken based diet
and two cats to the hydrolyzed soy based diet. Two of
these cats, one from each dietary group produced
detectable IL-10 prior to consuming the hydrolyzed diet.
All nine cats in this study had been sensitized to chicken
and soy, as both ingredients were present intact in the
previously fed diets, including the basal diet. This may
suggest that if an animal was allergic to chicken or soy,
then they may be able to recognize and react to the
hydrolyzed forms of these proteins. This has been shown
in one study, where 21% of dogs sensitized to the intact
protein still reacted adversely to the hydrolyzed diet [6].
One possible cause for the persistence of clinical signs
could be due to retention of larger sized or intact pro-
teins in the hydrolyzed diet. Therefore, determining not
just the average but also the range of sizes of hydrolyzed
proteins in these diets and correlating this to the
production of IL-10 in these cats may be beneficial to
help predict tolerance.
None of the three cats in the hydroSC group produced
detectable amounts of TNF-alpha, IL-10, or IL-4 when
stimulated with their respective hydrolyzed soy and
chicken based diet, prior to or after 6 weeks of con-
sumption. It is possible that this hydrolyzed diet did not
elicit a cytokine response due to the size and nature of
the hydrolyzed proteins. However, according to the
manufacturer of this diet, the average size of the dietary
protein is 12 kDa, whereas the other two hydrolyzed
diets are reported to have an average size of 10 kDa or
less. However, the range of protein sizes for each diet
was unspecified. If larger proteins persisted after
hydrolysis, this might explain the discrepancy between
the average protein size of the hydrolyzed diet and the
respective cytokine response. Also, this study was con-
ducted over a 6-week period and therefore it is possible
that with a longer duration of consumption of the
hydrolyzed soy and chicken based diet a cytokine
response may have been seen. In addition, the individual
differences in production of IL-10 to different hydro-
lyzed diets could also be explained by potential differ-
ences in peripheral lymphocyte count and the presence
of dietary antigen specific immunoglobulins.
Interestingly, two of three of the cats in the hydroSC
group produced TNF-alpha when stimulated with the
basal diet following the 6-week diet trial. These were the
only cats that produced no detectable IL-10 when their
ex-vivo whole blood was stimulated with the basal diet
following 6-weeks of hydrolyzed diet. The exact reason
for this result is unknown, but the lack of IL-10 produc-
tion may have prevented dampening of the TNF-alpha
response that normally occurs following IL-10 produc-
tion. In addition, although the dietary stimulants used inthe ex-vivo whole blood stimulation assays had been
filtered using a 0.22 μm filter, it is possible that bacterial
remnants that are known to stimulate pattern recogni-
tion receptors (PRR) such as lipopolysaccharide (LPS)
may have been present and could have resulted in the
TNF-alpha response in these two cats. However, as the
same batch of dietary extract was used for all nine cats
and the majority of cats did not produce TNF-alpha on
stimulation with these extracts, it is unlikely that LPS or
other PRR ligands were present in significant amounts.
However, specific measurement of PRR ligands should
have been performed in order to refute this possibility.
The aim of this pilot study was to describe the
immunological effects of three commercially available
feline hydrolyzed dry diets before and after feeding ex-
clusively for 6 weeks compared to a basal diet containing
these proteins intact in individual healthy immunotoler-
ant cats using ex-vivo whole blood stimulation assays. A
small number of cats were enrolled in this pilot study in
an effort to reduce the number of animals used in a re-
search study with an unknown outcome. In addition,
only healthy immunotolerant cats were used. Several
studies have shown that various non-allergic animal
models can be used to assess immunogenicity of human
hydrolyzed milk or rice formulas [25–28]. In addition,
one study in healthy cats demonstrated immunogenicity
to dietary proteins when fed as either aqueous suspen-
sions or as part of canned diets [24]. Therefore, future
studies will focus on the use of this assay in a larger
number of immunologically naïve, sensitized or clinically
hypersensitized cats to determine if the cytokine re-
sponse to hydrolyzed diets is similar to their basal diets
containing the same proteins intact. This study focused
on ex-vivo whole blood incubation for 24 h as this time
frame was shown to result in measurable cytokine secre-
tion in healthy immunotolerant children following whole
blood stimulation with milk antigen, after which time
lower levels were detected due to degradation [7].
Although our study was able to detect measurable
amounts of IL-10 protein in the supernatants of the ma-
jority of cats following stimulation with their basal diet
and in some cats following stimulation with some hydro-
lyzed commercial diets after 24 h, a longer incubation
time may have been needed to fully assess lymphocyte
derived cytokine production. Therefore, future studies
will aim to focus on different incubation times to help
confirm an optimum time for cytokine production
following incubation with dietary antigens. In addition,
future studies will also focus on the use of ex-vivo
intestinal biopsy stimulation assays to determine the
correlation of cytokine production between whole blood
and intestinal mucosa to confirm if whole blood can be
used as a surrogate for intestinal tissue when stimulated
with diet.
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In conclusion, this pilot study for the first time showed
that the majority of cats produced IL-10 to their basal
diet using an ex-vivo whole blood stimulation assay.
Similarly, some cats produced IL-10 to certain hydro-
lyzed therapeutic diets. This may suggest that in some
healthy immunotolerant cats, some hydrolyzed diets
may elicit a similar cytokine response compared to their
basal diet, which contained the same proteins intact,
however studies using a larger number of cats and
addressing some of the limitations of the current study
would be needed to corroborate this. In addition, further
studies are needed to determine the immunological
response to basal and hydrolyzed diets in immunologic-
ally naïve, sensitized or clinically hypersensitized cats.Endnotes
1Whiskas® Kitten Dry with Chicken. Mars Incorporated,
Fairfax County, VA. Main ingredients: poultry by-product
meal, corn gluten meal, soybean meal, brewers rice,
ground yellow corn, ground wheat, animal fat, and natural
chicken and turkey flavors.
2Purina Cat Chow® Complete Formula® dry cat food.
Nestle Purina PetCare Company, St Louis, MO.
Ingredients: poultry by-product meal, corn meal, corn
gluten meal, ground whole wheat, brewers rice, soy flour,
animal fat preserved with mixed-tocopherols, fish meal,
animal liver flavor, and meat and bone meal.
3Hill’s Prescription Diet Feline z/d dry food. Hill’s Pet
Nutrition Inc., Topeka, KS. Ingredients: brewers rice,
hydrolyzed chicken liver, soybean oil, powdered cellulose,
and chicken liver flavor.
4Purina Pro Plan Veterinary Diets Feline HA dry food.
Ingredients: rice starch, hydrolyzed soy protein isolate,
partially hydrogenated canola oil, hydrolyzed chicken
liver, tricalcium phosphate, powdered cellulose, corn oil,
and hydrolyzed chicken.
5Royal Canin Veterinary Diet Feline Hydrolyzed Protein
dry food. Royal Canin Inc. St. Charles, MO. Ingredients:
brewers rice, hydrolyzed soy protein, and chicken fat.
650 ml Sterile Centrifuge Tubes. Corning®. Corning
Incorporated, Corning, NY.
7Millex ® GP Filter Unit, PES Membrane. Merck
Millipore Ltd. Tullagreen, Co. Cork, IRL.
8Sterile culture hood, Class II Type S/B3.
9Bradford Reagent. Amresco, Solon, OH.
10PBS. Hyclone Laboratories, South Logan, UT.
11RPMI with L-glutamine, Corning Cellgro ®. Mediatech,
Inc. Manassas, VA.
12Corning Costar ®24 Well Plate, individually wrapped,
sterile.
13Hera Cell Incubator. Thermo Fischer Scientific Inc.
Waltham, MA.14Feline TNF-alpha DuoSet ELISA. R&D Systems, Inc.
Minneapolis, MN.
15Feline IL-10 DuoSet ELISA. R&D Systems, Inc.
16Feline IL-4 DuoSet ELISA. R&D Systems, Inc.
17Bio-Tek Synergy H1 Multi-Mode Reader. Bio-Tek
Instruments Inc. Winooski, VT.
18Gen5 Microplate Reader and Imager Software. Bio-Tek
Instruments Inc.
Abbreviations
AFR: Adverse food reaction; HydroC: Hydrolyzed chicken based diet;
HydroS: Hydrolyzed soy based diet; HydroSC: Hydrolyzed soy and chicken
based diet; IL: Interleukin; TNF: Tumor necrosis factor; RPMI: Roswell Park
Memorial Institute; PBS: Phosphate buffered saline; PBMC: Peripheral blood
mononuclear cells
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